drugset / Trial / NCT00000231

Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13

NCT00000231 ↗

Treatment

Summary

The purpose of this study is to evaluate buprenorphine and behavioral treatment with and without contingent payment on compliance with pro-social activities. In addition, we will examine whether blind naltrexone dosing is effective in indicating naltrexone consumption.

Timeline

Start
1992-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —